Pfizer touts successor to Prevnar 13

Pfizer touts successor to Prevnar 13

Source: 
Biopharma Dive
snippet: 

Phase 2 data showed Pfizer's experimental pneumococcal vaccine to be safe, boosting confidence in what Pfizer hopes will be a follow-on to Prevnar 13.